Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB) [2]

R. Sorio, E. Galligioni, D. Crivellari, R. Talamini, S. Monfardini

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)306-307
Number of pages2
JournalAnnals of Oncology
Issue number3
Publication statusPublished - 1995

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this